» Articles » PMID: 21554855

A Pragmatic Single-blind Randomised Controlled Trial and Economic Evaluation of the Use of Leukotriene Receptor Antagonists in Primary Care at Steps 2 and 3 of the National Asthma Guidelines (ELEVATE Study)

Overview
Specialty Biotechnology
Date 2011 May 11
PMID 21554855
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis.

Mayoral K, Lizano-Barrantes C, Zamora V, Pont A, Miret C, Barrufet C Eur Respir Rev. 2023; 32(170).

PMID: 37852659 PMC: 10582929. DOI: 10.1183/16000617.0124-2023.


The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review.

Menzella F, Galeone C, Ghidoni G, Ruggiero P, DAmato M, Fontana M Multidiscip Respir Med. 2021; 16(1):787.

PMID: 34557301 PMC: 8404525. DOI: 10.4081/mrm.2021.787.


Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review.

Rodriguez-Martinez C, Sossa-Briceno M, Castro-Rodriguez J Pharmacoeconomics. 2018; 36(10):1165-1200.

PMID: 29869050 DOI: 10.1007/s40273-018-0668-8.


Add-on LABA in a separate inhaler as asthma step-up therapy increased dose of ICS or ICS/LABA combination inhaler.

Price D, Colice G, Israel E, Roche N, Postma D, Guilbert T ERJ Open Res. 2016; 2(2).

PMID: 27730200 PMC: 5005184. DOI: 10.1183/23120541.00106-2015.


Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.

Chauhan B, Ducharme F Cochrane Database Syst Rev. 2014; (1):CD003137.

PMID: 24459050 PMC: 10514761. DOI: 10.1002/14651858.CD003137.pub5.